The hemp seed oil market is projected to expand from USD 0.15 billion in 2026 to USD 0.86 billion by 2036, registering a 19.2% CAGR. Growth is being shaped by tighter purchasing controls in food, nutraceutical, and personal care value chains where buyers increasingly treat input selection as a governance decision rather than a simple sourcing step.
Commercial adoption is also benefiting from wider product portfolio planning, where brands and manufacturers seek scalable ingredient availability across multiple categories. Procurement cycles are becoming more specification-led, with greater focus on batch consistency, documentation readiness, and repeat supply performance across long replenishment windows.
| Metric | Value |
|---|---|
| Market Value (2026) | USD 0.15 billion |
| Market Forecast Value (2036) | USD 0.86 billion |
| Forecast CAGR (2026 to 2036) | 19.2% |
Hemp seed oil demand is rising because buyers are narrowing supplier selection to partners that can support predictable specifications and documentation depth. Food and nutraceutical decision-makers increasingly prioritize certificate completeness, traceable sourcing routines, and repeatable quality outcomes across lot cycles. This reduces risk when products enter high-visibility channels and regulated environments.
Commercial scale-up also reflects tighter contaminant and threshold controls in food systems. Regulatory maximum levels and monitoring practices are influencing how companies structure testing plans and supplier onboarding routines, shaping more formal procurement behavior. Commission Regulation (EU) 2023/915 sets maximum levels for certain contaminants in food, including specific thresholds for hemp seed oil
Category momentum also aligns with broader portfolio development across related hemp-derived ingredient lanes where companies manage distinct positioning boundaries. This separation is increasingly important in governance and labeling workflows, especially where product teams maintain clarity between seed-derived inputs and cannabinoid-focused formulations.
Conventional holds a 62.4% share, reflecting purchasing behavior that prioritizes availability, scalability, and supply continuity across large-volume applications. Many buyers treat conventional sourcing as a practical pathway for stable inventory planning, especially when procurement targets predictable replenishment across multiple product lines.
Organic demand remains active where buyers align ingredient selection with premium positioning and sourcing standards. Volume scaling often depends on supplier capacity and the ability to support consistent grade documentation over long production runs.
Food grade leads with a 69.1% share, supported by the scale of consumption linked to food-facing applications and the need for clear compliance documentation. Buyers increasingly view grade selection as a control point that simplifies downstream acceptance across manufacturing and retail distribution chains.
Pharmaceutical grade remains relevant where internal qualification requirements are more stringent and documentation depth becomes central to procurement. This segment expands through selective uptake tied to defined production programs.
Cold pressed accounts for a 78.0% share, reflecting preference for processes that align with repeatable quality expectations and predictable sourcing narratives within customer approval routines. Buyers often use extraction process selection as part of supplier validation, especially when product claims and internal quality checks depend on process consistency across batches.
Refined products support demand where customers prioritize controlled consistency and standardized input behavior across production, particularly in applications that value predictable formulation performance.
Food & beverage holds a 44.0% share, supported by recurring purchasing cycles and the ability to scale volumes through multi-product portfolio use. Buyers in this segment often require dependable supply continuity and stable quality verification routines, which increases retention for suppliers that pass qualification benchmarks.
Nutraceuticals contribute through structured product pipelines where procurement teams align ingredient sourcing with repeatable documentation and long-cycle replenishment. Cosmetics & personal care maintains demand where brands seek consistent input quality and stable supplier assurance. Pharmaceuticals and industrial products add portfolio breadth, supporting more resilient growth across cycles.
Scale-up is supported by increasing standardization in purchasing programs where buyers prefer suppliers that can deliver repeatable outcomes across batches and stable documentation across shipments. Cold pressed leadership and food grade dominance reflect this structured procurement behavior, which limits switching once a supplier is embedded into routine replenishment schedules.
This purchasing logic mirrors the broader expansion tracked in the global hemp seed oil space, where demand growth is tied to food, nutraceutical, and personal care channels.
Contaminant thresholds are strengthening the role of testing discipline and supplier validation in procurement. Companies are increasing reliance on documented conformance and consistent verification pathways, which can extend onboarding timelines while improving supplier retention after approval. The EU framework for maximum levels under Commission Regulation (EU) 2023/915 is one of the regulatory references influencing these quality routines.
Switching is slowed by the cost of requalification, changes in internal testing baselines, and the operational risk of variability across lots. Buyers often maintain continuity once a supply partner meets acceptance thresholds, since any disruption can affect product planning and downstream customer confidence.
Country-level momentum varies based on category scaling pace, procurement maturity, and the rate at which product portfolios expand across food-facing and personal care channels.
| Country | CAGR (%) |
|---|---|
| USA | 18.7% |
| UK | 19.0% |
| Japan | 18.4% |
| South Korea | 19.2% |
South Korea is projected to expand at a 19.2% CAGR, reflecting rapid scaling as buyers increase adoption across food-facing and personal care pipelines. Growth benefits from structured portfolio expansion where brands prioritize repeat supply performance and consistent documentation to support routine replenishment.
The UK is expected to grow at a 19.0% CAGR, shaped by purchasing environments where supplier validation and quality discipline influence long-term ordering. Growth is reinforced when product pipelines expand across multiple end-user channels while procurement systems maintain stable approval routines.
The USA is forecast to advance at an 18.7% CAGR, supported by diversified demand across food & beverage and nutraceutical pipelines. Growth benefits from expanding availability and structured sourcing behavior, including increased attention to hemp seed production and supply tracking frameworks reported by USDA National Agricultural Statistics Service.
Japan is projected to grow at an 18.4% CAGR, reflecting controlled scale-up where buyers prioritize supplier assurance and repeatable outcomes. Demand expands as product programs move from selective adoption into routine procurement supported by stable documentation and quality verification.
Competition is shaped by grade management, documentation readiness, and supply reliability across recurring procurement cycles. Suppliers differentiate through consistency across lots, ability to meet verification expectations, and alignment with customer requirements for quality assurance records.
Portfolio strength also matters. Vendors that can serve food grade demand while supporting structured entry into nutraceutical and personal care programs are better positioned to secure repeat contracts. Growth advantages strengthen when suppliers can scale production without sacrificing batch consistency or delivery reliability.
| Items | Values |
|---|---|
| Quantitative Units | USD Billion |
| Product Type | Conventional; Organic |
| Grade | Food Grade; Pharmaceutical Grade |
| Extraction Process | Cold Pressed; Refined |
| End User | Food & Beverage; Nutraceuticals; Cosmetics & Personal Care; Pharmaceuticals; Industrial Products |
| Key Countries | USA; UK; Japan; South Korea |
| Key Companies Profiled | Nutiva Inc.; Canopy Growth Corporation; Connolis LLC; Maverik Oils; NP Nutra; Hemp Oil; Agropro; Canah International SRL; Z-Company; Ecofiber Limited |
What is the projected hemp seed oil market size for 2026?
The hemp seed oil market is expected to total USD 0.15 billion in 2026.
What value is expected for hemp seed oil in 2036?
In 2036, demand for hemp seed oil is forecast to reach USD 0.86 billion.
At what rate will the hemp seed oil market progress from 2026 to 2036?
Hemp seed oil demand is expected to grow at a 19.2% CAGR during 2026 to 2036.
Which product type leads demand and what share does it hold?
Conventional leads by product type with a 62.4% share.
Which grade leads demand and what share does it hold?
Food grade leads by grade with a 69.1% share.
Which extraction process leads demand and what share does it hold?
Cold pressed leads by extraction process with a 78.0% share.
Which end user leads demand and what share does it hold?
Food & beverage leads end users with a 44.0% share.
Full Research Suite comprises of:
Market outlook & trends analysis
Interviews & case studies
Strategic recommendations
Vendor profiles & capabilities analysis
5-year forecasts
8 regions and 60+ country-level data splits
Market segment data splits
12 months of continuous data updates
DELIVERED AS:
PDF EXCEL ONLINE
Hemp Seed Oil Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
